Drug Database
OR

Ortho-ACI

✓ Approved

Orthocell Pty, Ltd. · 细胞治疗 · 细胞治疗

什么是 Ortho-ACI?

Ortho-ACI 是一种细胞治疗,由Orthocell Pty, Ltd.研发。该药已获批,用于治疗相关适应症,给药途径:Surgical Implantation。

药物档案

公司Orthocell Pty, Ltd.
药物类别细胞治疗
给药途径Surgical Implantation
状态Approved

治疗适应症

Ortho-ACI 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Musculoskeletal and connective tissue disordersChondropathy✓ Approved

相关研究文献

PubMedParasites & vectors2026-11-19

Probiotic potential of Blautia producta L1 in mitigating Eimeria tenella-induced intestinal inflammation and dysbiosis in chickens.

Liu Jianhua J, Yuan Cheng C, Zhang Guangji G, Zhao Changjing C et al.

The capacity of Blautia to restore microbial homeostasis and attenuate intestinal inflammation highlights its potential as a promising microbial therapeutic for poultry coccidiosis. A total of 75 one-day-old male Hy-Line layer chicks were randomly allocated into five groups (n=15 per group): mock control, challenged control, B. producta L1 control, B. producta L1-challenged, and inactivated B. producta L1-challenged. From day 1 to day 22, chickens in the B. producta L1-treatment groups were orally administered either live or heat-inactivated B. producta L1 at 2 × 10⁸ CFU/mL (1 mL/bird) once daily. On day 14, chickens in the challenged groups were orally gavaged with 3 × 104 sporulated E. tenella oocysts. Protective efficacy was assessed by body weight gain, fecal oocyst out, cecal lesion score (0-4), and histopathological examination of intestinal epithelium. The anticoccidial index (ACI) was also calculated. Inflammatory cytokines including IL-1β, IL-6, TNF-α, and IL-10 were analyzed by ELISA, and mRNA expression of genes related to cecal inflammatory pathways was analyzed by qRT-PCR. The composition of the cecal microbiota was profiled using 16S rRNA gene sequencing. Supplementation with either live or heat-inactivated B. producta L1 conferred measurable protection against E. tenella challenge. Body weight gain in the live and inactivated B. producta L1-treated groups was significantly greater than that of the challenged control group (p < 0.01). Cecal lesion scores and fecal oocyst output were markedly reduced in both B. producta L1-treated groups compared with the challenged control group (p < 0.001 for both). Survival was 100% in both B. producta L1-treated groups and 86.7% (13/15) in the challenged control group. However, the between-group difference in survival was not statistically significant. The ACI values of the live and inactivated B. producta L1-treated groups were 162.0 and 151.6, respectively, corresponding to medium-effective and effective protection according to the established ACI criteria, compared with 102.2 in the challenged control group. Histopathological examination showed less epithelial degeneration, necrosis, and villus atrophy in B. producta L1-treated birds. Moreover, B. producta L1 supplementation significantly decreased serum concentrations of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α; p < 0.01) and increased the anti-inflammatory cytokine IL-10 (p < 0.05), while downregulating mRNA expression of TLR4, MYD88, NF-κB, NLRP3, P65, and Caspase-3 in cecal tissues (p < 0.05 for all). 16S rRNA gene sequencing further demonstrated that B. producta L1 increased cecal microbial richness and diversity, with higher relative abundances of beneficial genera such as Blautia and Lactobacillus and lower abundances of potentially pathogenic taxa including Salmonella, Acinetobacter, and Erysipelatoclostridium (p < 0.05). B. producta L1 moderately ameliorates E. tenella-induced pathology by helping preserve intestinal barrier integrity, dampening inflammatory responses, and reshaping the gut microbial ecosystem. These findings support B. producta L1 as a promising probiotic or postbiotic candidate for complementary control of E. tenella infection in poultry, although further benchmarking against standard anticoccidial agents and identification of active bioactive components are required.

PMID 43053077
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Single-Carbon Atom Insertion into Phenols with Nitroalkanes.

Chi Changli C, Liang Jiayu J, Wu Haozhe H, Zhang Jun J et al.

The catalytic conversion of phenols into high-value structural motifs via benzene ring skeletal reconstruction remains a significant challenge in organic synthesis, particularly through single-carbon atom insertion. Traditional methods, such as the Büchner reaction, are constrained by the use of reactive carbenoid C1 synthons, poor tunability of site-selectivity, and limited scalability. Herein, we describe that simple nitroalkanes, under copper catalysis and aerobic conditions, serve as practical noncarbenoid C1 sources for direct single-carbon atom insertion into phenols. The insertion site can be diverted from the C2═C3 bond to the C1═C2 bond upon simple addition of AlCl3, thereby enabling access to two distinct classes of tropones with excellent site-selectivity. The nitro group serves three essential roles─as an electron-withdrawing group, a directing group, and a leaving group──enabling oxidative dearomative ortho-alkylation and subsequent ring reconstruction. The method tolerates a wide range of functional groups and heteroarenes, operates on a 100-g scale with low cost, and allows kinetic resolution of axially chiral 2-naphthols with up to 98% ee. This work establishes nitroalkanes as a new class of C1 building blocks and unlocks programmable skeletal editing of phenols for synthetic and materials applications.

PMID 43053383
阅读全文 →
PubMedAnalytical chemistry2026-11-18

Click-Derived 1,4-Disubstituted 1,2,3-Triazoles as Efficient Fluorogenic Chemosensors: Harnessing CuAAC for Anion Recognition.

Hazarika Roktopol R, Das Alok Kumar AK, Gogoi Priyanka P, Nath Dipankar D et al.

This work explores the design, synthesis, and analytical investigations of novel fluorogenic chemosensors based on the 1,2,3-triazole moiety engineered to respond selectively to fluoride and cyanide anions. The rationale for selecting the triazole-based receptor lies on the ability of 1,2,3-triazoles to recognize anions through their polarized Csp2-H proton, together with an ortho-substituted phenolic-OH group through a cooperative mechanism. The ortho-substituted phenolic-OH provides receptor preorganization as well as an acidic hydrogen, facilitating analyte-induced deprotonation by a basic anion. The resulting phenoxide is stabilized by conjugative delocalization, producing a pronounced UV-visible response toward F- and CN-. The sensing behavior has been evaluated in DMSO using both UV-visible absorption and fluorescence emission spectroscopy. The appearance of a new absorption peak along with the original absorption peak of the sensor as well as quenching of the emission peak upon addition of the analyte to the sensor significantly implies successful recognition. Key performance metrics, such as binding affinities of 4.09 × 103 M-1 for CN- with phenyl 2-((1-(2-hydroxyphenyl)-1H-1,2,3-triazol-4-yl)methoxy)benzoate (3aa), stoichiometric ratios, as well as detection limits of 17.2 μM for CN- with 3aa have been evaluated with the help of UV-visible absorption spectroscopy and have been performed for all the receptor molecules. To demonstrate practical utility, the chemosensor was successfully employed to detect cyanide in sprouted potatoes quantitatively. Further, a DFT study has also been conducted which successfully validates the proposed sensing mechanism.

PMID 43046451
阅读全文 →
PubMedScience advances2026-11-18

Recovery and resurrection of chiral homogeneous catalysts for closed-loop recycling.

Liu Shiqi S, Arafah Najwa N, Huang Jingjun J, LaPierre Etienne A EA et al.

Homogeneous catalysis by transition metal complexes is essential for chemical synthesis; however, these processes remain unsustainable because the catalysts are generally not recovered. We address this problem with a framework for closed-loop catalyst recycling. This approach centers on two chemical processes: stasis, where catalytic activity is selectively halted while retaining molecular integrity; and anastasis, where full catalytic function is restored. We apply this framework to recycle chiral palladium catalysts used for asymmetric allylic alkylation. ortho-Quinone oxidants drive the catalyst to converge on a discrete PdII complex that is readily recovered, while mild reductants regenerate active Pd0 precatalysts in a subsequent step. By rendering catalyst deactivation, isolation, and reactivation chemically addressable, this work is an important step toward circular, resource-efficient synthesis.

PMID 43050553
阅读全文 →
PubMedAnalytical chemistry2026-11-18

NTR-Activated NIR-I Photosensitizer for Ultrasensitive Hypoxia Tumor Imaging and Photodynamic Therapy.

Sun Xueyi X, Zhao Wenjing W, Xue Zheyuan Z, Jia Xiaohui X et al.

Nitroreductase (NTR), overexpressed in solid tumors, is a specific biomarker indicating tumor hypoxia. NTR-activatable photosensitizers are an effective approach for tumor theranostics. However, challenges such as slow response, imprecise tumor recognition, and weak photodynamic effects under hypoxic conditions limit their utility in cancer imaging and therapy. Using an iodinated xanthene-cyanine near-infrared fluorescent scaffold, we developed a series of NTR-activatable photosensitizers, IX-NO2-H, IX-NO2-F, and IX-NO2-CF3, incorporating 4-nitrophenyl as the NTR-responsive unit with different ortho-substituents. Upon NTR and NADH activation, the nitro group is reduced to an amino group, triggering the release of the photosensitizer through a self-immolative reaction. Spectral analyses and molecular docking experiments revealed that IX-NO2-CF3, based on 3-trifluoromethyl-4-nitrophenyl, exhibited the best performance, showing rapid NTR response (<7 min) and a substantial fluorescence increase (∼78-fold) at 718 nm. In addition, owing to its specific activation by endogenous NTR, IX-NO2-CF3 was successfully used to evaluate the degree of hypoxia in cancer cells and tumor-bearing mice while exhibiting excellent mitochondrial targeting ability (Mander's overlap coefficients >0.9). Upon laser irradiation, significant generation of reactive oxygen species, including singlet oxygen (1O2) and superoxide anion (O2•-), from IX-NO2-CF3 post NTR activation induced cancer cell apoptosis and effectively suppressed tumor growth through NTR-activated type I and/or II photodynamic therapy under normoxic and severely hypoxic conditions. This study presents a novel strategy for highly sensitive tumor hypoxia imaging and an NTR-triggered photosensitizer for accurate cancer therapy (80% TGI) with minimal side effects.

PMID 43046431
阅读全文 →
PubMedRSC advances2026-11-18

Induction of breast cancer cell apoptosis by novel pyrrolo[2,3-d]pyrimidine analogs through modulation of the Bax/Bcl-2 ratio.

Khademi Ashkan A, Sayahi Mohammad Hosein MH, Irajie Cambyz C, Haghpanah Vahid V et al.

Breast cancer remains one of the most commonly diagnosed malignancies worldwide, and developing novel cytotoxic agents that overcome therapeutic resistance remains a major priority in anticancer drug discovery. Building on the pyrrolo[2,3-d]pyrimidine scaffold of tofacitinib, a series of fifteen tofacitinib-derived analogs (5a-n) with aryl substitutions was synthesized and evaluated for cytotoxic activity against Hep-G2, PC-3, and MCF-7 cancer cell lines. Structure-activity relationship (SAR) analysis revealed that para-substitution outperformed ortho-substitution, and among halogens, potency followed the order: Br > Cl > F. The para-bromo analog 5e emerged as the most potent compound against MCF-7 cells (IC50 = 0.99 ± 0.20 µM) and showed strong activity against PC-3 (10.70 ± 0.45 µM). Flow cytometric analysis showed that 5e induced a concentration-dependent response in MCF-7 cells, causing a significant G1 cell cycle arrest that effectively blocks the G1/S transition checkpoint. This block induced programmed cell death, resulting in pronounced late apoptosis (64.5% vs. 1.06% in the control) and a 9.4-fold increase in the Bax/Bcl-2 ratio. To explore a plausible mechanism of action for compound 5e, in silico docking and molecular dynamics simulations against the JAK1 ATP-binding pocket were also performed. Together, these results identify 5e as a promising anticancer lead and provide a validated structural template for linking the pyrrolo[2,3-d]pyrimidine scaffold to cytotoxic and pro-apoptotic activity. When combined with mechanistic and computational evidence, the clear SAR trends based on halogen type and position provide strong support for optimizing the next generation of anticancer agents, especially in the context of therapeutic resistance in breast cancer.

PMID 43048348
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多Ortho-ACI